Navigation Links
Cellectis to Present at the American Society of Gene & Cell Therapy Annual Meeting
Date:5/11/2010

PARIS, May 11 /PRNewswire-FirstCall/ -- Cellectis (Alternext: ALCLS), the French genome engineering specialist, announces today that Frederic Paques, PhD, Chief Scientific Officer, has been invited to present Cellectis' approaches on vectors for meganucleases and genome surgery at the 13th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting to be held at the Marriott Wardman Park Hotel in Washington, USA, on May 19-22, 2010.

Targeted approaches have emerged today as an alternative to current random insertion strategies for gene therapy. Meganucleases, the most specific endonucleases, represent ideal tools for targeted genome editing, or genome surgery. They can induce up to 20% of gene insertion into chosen human genes. The entry of meganucleases into different cell types can be achieved by various means, including viral and non-viral vectorization.

Dr Paques will discuss "Meganucleases and Viral Vectors: Alternative or Complementary Approaches" on May 22, 2010, at 8:30AM, during an oral session on Special Considerations with Using Viral Vectors for Gene Modification of Stem Cells.

About Cellectis

Cellectis is a pioneer in the field of genome engineering. The company designs and markets innovative tools - meganucleases. These molecular scissors enable targeted modifications to DNA, with applications in the research, biomanufacturing, agrobiotechnology and therapeutic sectors.

To date, Cellectis has formed over 20 academic research partnerships and has established more than 50 agreements with pharmaceutical laboratories, seed producers and biotech companies across the world. The company
'/>"/>

SOURCE Cellectis
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Monsanto Licenses Use of Cellectis Innovative Genome Modification Technology
2. Cellectis and Regeneron Sign an Agreement Over the use of Homologous Recombination Technology
3. Cellectis Sues Precision BioSciences for Infringement of its Patents Concerning Meganuclease Technology
4. Zymes LLC, University of Windsor and National Research Council of Canada Collaborative Research Presented at the 2010 Experimental Biology Meeting in Anaheim, California
5. BioMed Realty Trust to Webcast Company Presentation at Investor Day 2010
6. Dyadic International to Present at Rodman & Renshaw 6th Annual Global Healthcare Conference
7. Neuralstem, Inc. to Present At World Stem Cells and Regenerative Medicine Congress
8. Yongye International to Present at Upcoming Investor Conferences
9. Cardium to Present at MDB Capital Groups 2010 Bright Lights Conference
10. Talecris Biotherapeutics to Present at the Bank of America Merrill Lynch Health Care Conference
11. Brazilian Biotechnology Present at BIO 2010 Is Looking for the Worldwide Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... OAKS, Calif. , July 25, 2014 ... Board of Directors today declared a $0.61 per share ... will be paid on Sept. 5, 2014, to all ... on Aug. 14, 2014.  About Amgen ... for patients suffering from serious illnesses by discovering, developing, ...
(Date:7/25/2014)... , July 25, 2014 ... the "Global Metabolomics Market 2014-2018" report ... http://photos.prnewswire.com/prnh/20130307/600769 Metabolomics or Metabonomics is ... Metabolomics has become a new experimental technique that ... the environmental sciences. Metabolites are small molecules that ...
(Date:7/25/2014)... July 25, 2014 The Conferee Networking ... Topics for Conferee Networking. These two-hour sessions provide a ... meet and resolve problems, discuss new techniques, or brainstorm ... to submit a topic for consideration is August 31, ... . The Conferee Networking committee will review the topics, ...
(Date:7/25/2014)... 2014 /PRNewswire-iReach/ -- Xybion Corporation, the leading provider ... operating in highly regulated industries, announced today that ... User Group Conference, Xybion International Exchange, on October ... at the Sheraton Society Hill Hotel.  ... This year,s conference theme is Compliance ...
Breaking Biology Technology:Amgen Announces 2014 Third Quarter Dividend 2Amgen Announces 2014 Third Quarter Dividend 3Global Metabolomics Market 2014-2018: Key Vendors are Agilent, Bio-Rad, Bruker, Human Metabolome and Metabolon 2Pittcon 2015 Announces Call for Topics for Conferee Networking Sessions 2Xybion Announces It Will Host International User Conference in Philadelphia 2Xybion Announces It Will Host International User Conference in Philadelphia 3
... valuable source of biofuel. Researchers writing in BioMed Central,s ... shown that the juice of reject watermelons can be ... a team of researchers at the USDA-Agricultural Research Service,s ... to evaluate the biofuel potential of juice from ,cull, ...
... , , NEW YORK, ... filed suit yesterday against Celgene Corporation (Nasdaq: CELG ... "unjust enrichment" regarding the Company,s sale of thalidomide (THALOMID(R) and ... alleges that Ms. Jacobson developed the original and novel idea ...
... , , SAN ... ), a biopharmaceutical company focused on developing and commercializing novel pain ... its Board of Directors as a director and Audit Committee chairman, ... CEO of Keren Pharmaceutical, a company focused on exploiting a novel, ...
Cached Biology Technology:NeurogesX Appoints New Board Director and Audit Committee Chairman 2NeurogesX Appoints New Board Director and Audit Committee Chairman 3NeurogesX Appoints New Board Director and Audit Committee Chairman 4NeurogesX Appoints New Board Director and Audit Committee Chairman 5
(Date:7/24/2014)... wildlife loss leads to conflict among people around the ... Society (WCS) Health & Ecosystems: Analysis of Linkages (HEAL) ... approach to tackle global biodiversity decline. , The harvest ... world,s people and provides protein for more than a ... no surprise that today,s unprecedented loss of wildlife, is ...
(Date:7/24/2014)... 2014) Scientists at The New York Stem ... closer to creating a viable cell replacement therapy ... , For the first time, NYSCF scientists ... skin samples of patients with primary progressive multiple ... to induce these stem cells into becoming oligodendrocytes, ...
(Date:7/24/2014)... effects on different species of fish, according to ... and Exeter which tested fish anti-predator behaviour. ... seagull predator model when exposed to additional noise, ... , Lead author Dr Irene Voellmy of ... in many aquatic environments have increased substantially during ...
Breaking Biology News(10 mins):New study draws links between wildlife loss and social conflicts 2NYSCF scientists 1 step closer to cell therapy for multiple sclerosis patients 2
... In the May 15th issue of G&D, Dr. Michael Carey ... into the mechanism of epigenetic silencing of euchromatic genes. ... direction to understand how histone and DNA methylation, two phenomena ... cancer, can communicate with each other to turn genes off. ...
... a mystery why the speed and complexity of evolution appear ... that single-celled life first appeared about 3.5 billion years ago, ... multi-cellular life to evolve. That leaves just a billion years ... plants, mammals, insects, birds and other species that populate the ...
... have developed an inexpensive, nonchlorine-based technology that can ... , UD's patented technology, developed jointly by ... Resources and the College of Engineering, incorporates highly ... a chemical "knock-out punch" to a host of ...
Cached Biology News:Does evolution select for faster evolvers? 2New UD technology removes viruses from drinking water 2New UD technology removes viruses from drinking water 3New UD technology removes viruses from drinking water 4
...
Mouse monoclonal [Ley 37D/G6] to LKB1 ( Abpromise for all tested applications). entrezGeneID: 6794 SwissProtID: Q15831...
... phase reagent for Virus ... & unique water insoluble ... detergents and chaotropes; Engineered ... non-envelop viruses while preserving ...
Integrins Sampler Kit 10g each...
Biology Products: